MarketWatch.com - Top Stories

Eli Lilly cuts price of weight-loss drug Zepbound for self-paying patients

The drug company is calling on insurers and federal programs to include coverage of obesity as a chronic disease.

Feb 25, 2025 - 13:56
 0
Eli Lilly cuts price of weight-loss drug Zepbound for self-paying patients
The drug company is calling on insurers and federal programs to include coverage of obesity as a chronic disease.
Read More

Tags:

Previous Article

Home Depot Earnings Outlook Is Soft. Here Is Why The Stock Is Up.

Next Article

Daily Spotlight: Inverted Yield Curve in Rear-View Mirror

Related Posts

Oil prices attempt to hold ground after Friday slump

Oil prices attempt to hold ground after Friday slump

Feb 24, 2025  0

UBS’s stock got clobbered after earnings. Deutsche Bank says it’s now a buy.

UBS’s stock got clobbered after earnings. Deutsche Bank...

Feb 11, 2025  0

Will my second wife be able to access my money if I transfer it to my retirement account?

Will my second wife be able to access my money if I tra...

Feb 20, 2025  0